(Alliance News) - BioPharma Credit PLC on Friday said it, alongside subsidiary BioPharma Credit Investments V Master LP, has agreed to buy senior secured notes of OptiNose US Inc for up to USD150 Read More
(Alliance News) - BioPharma Credit PLC said Wednesday the termination of an alliance between Sanofi SA and Lexicon Pharmaceuticals Inc enhances the collateral value behind its loan to - a debt - a Read More
(Alliance News) - BioPharma Credit PLC on Wednesday reported a rise in net assets over the first half following the acquisition of a portfolio company by pharma giant GlaxoSmithKline PLC.At Read More
(Alliance News) - Life science debt investor BioPharma Credit PLC declared a flat second quarter interim dividend.The USD0.02 per share dividend for the period ended June 30 is also flat is Read More
(Alliance News) - BioPharma Credit PLC on Tuesday noted the termination of Sanofi SA's collaboration and licence agreement with Lexicon Pharmaceuticals Inc over diabetes drug Credit, a life of Read More
LONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC has advanced up to USD80 million to a US-based investee, and also bought some of the company's shares, it said has the Read More
LONDON (Alliance News) - BioPharma Credit PLC on Tuesday said its net assets increased sharply in total in 2018 but two sizeable share placings meant that its net asset value per share was largely Read More
LONDON (Alliance News) - BioPharma Credit PLC on Tuesday said it will now receive a USD370.0 million loan repayment as GlaxoSmithKline PLC has completed its Tesaro Inc acquisition.The Glaxo Read More
LONDON (Alliance News) - BioPharma Credit PLC said Thursday it appointed Stephanie Leouzon as non-executive director with immediate effect.Currently, Leouzon is a partner and head at She on Read More
LONDON (Alliance News) - BioPharma Credit PLC on Thursday said it raised USD305 million after its proposed placing exceeded its upgraded issue size.The pharmaceutical focused investment at Read More
LONDON (Alliance News) - BioPharma Credit PLC's C shares were temporarily suspended from trading on the specialist fund segment of the London Stock Exchange pending an announcement by the in Read More
LONDON (Alliance News) - BioPharma Credit PLC said Wednesday it increased the size of its proposed placing to "at least" USD200 million due to strong investor demand.Last Friday, Read More
LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million shares at USD1.025 per share, a 2.9% to a Read More
LONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life sciences debt investment trust increased to Read More
LONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-focused biopharmaceutical company.Under in Read More
LONDON (Alliance News) - BioPharma Credit PLC said Monday it has funded, alongside other investors, the USD200 million second tranche of a USD500 million loan to TESARO Inc.The company and Read More
LONDON (Alliance News) - BioPharma Credit PLC said Friday Pablo Legorreta doubled his stake in the pharmaceutical debt investor in a transaction on Monday.Legorreta - the founder and chief Read More
LONDON (Alliance News) - Life-science focused debt investor BioPharma Credit PLC said on Wednesday Pharmaceutical Investors LP sold shares in the company on Tuesday.After the transaction a Read More
LONDON (Alliance News) - BioPharma Credit PLC said Tuesday that it has invested USD194 million in a unit of US-based Sebela Pharmaceuticals Inc.The life science-focused debt investor has a Read More
